Company intelligence / Profile preview
Ankh Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
01
Overview
Ankh Pharmaceuticals is a biotechnology company focused on the development of novel therapeutics targeting the biology of aging. The company leverages insights into sirtuin activation and metabolic pathways to create small molecule drugs aimed at extending healthy lifespan and treating age-related pathologies. Their research primarily centers on sirtuin modulators that can potentially address a broad range of conditions, including neurodegeneration and metabolic dysfunction. Ankh Pharmaceuticals aims to translate longevity science into clinical applications that improve human healthspan.
- Therapeutic areas
- NeurologyOtherMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Ankh Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ankh Pharmaceuticals.